 | • レポートコード：GIR-2104Z00998 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、138ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療・医薬品 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、抗腫瘍治療薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。抗腫瘍治療薬の種類別市場規模（化学療法剤、生物学的/免疫療法剤、個別化医療）、用途別市場規模（病院、診療所、がんリハビリテーションセンター、外来手術センター）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・抗腫瘍治療薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Hoffmann-La Roche、Amgen、Bristol-Myers Squibb、Baxter Healthcare、Boehringer Ingelheim、Aspen Global、Bayer AG、Teva pharmaceutical Industries、Johnson & Johnson、Merc & Co.、Pfize、Accord Healthcare、Genentech、Lundbeck、AbbVie ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：化学療法剤、生物学的/免疫療法剤、個別化医療 ・用途別分析2016年-2026年：病院、診療所、がんリハビリテーションセンター、外来手術センター ・抗腫瘍治療薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・抗腫瘍治療薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・抗腫瘍治療薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・抗腫瘍治療薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・抗腫瘍治療薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Antineoplastic Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Antineoplastic Drugs size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Antineoplastic Drugs market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Antineoplastic Drugs market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Chemotherapeutic Agents
Biological/Immunotherapeutic Agents
Personalized Medicine
Market segment by Application can be divided into
Hospitals
Clinics
Cancer Rehabilitation Centers
Ambulatory Surgical Centers
The key market players for global Antineoplastic Drugs market are listed below:
Hoffmann-La Roche
Amgen
Bristol-Myers Squibb
Baxter Healthcare
Boehringer Ingelheim
Aspen Global
Bayer AG
Teva pharmaceutical Industries
Johnson & Johnson
Merc & Co.
Pfize
Accord Healthcare
Genentech
Lundbeck
AbbVie
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Antineoplastic Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Antineoplastic Drugs Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Chemotherapeutic Agents
1.2.3 Biological/Immunotherapeutic Agents
1.2.4 Personalized Medicine
1.3 Market Analysis by Application
1.3.1 Overview: Global Antineoplastic Drugs Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Cancer Rehabilitation Centers
1.3.5 Ambulatory Surgical Centers
1.4 Global Antineoplastic Drugs Market Size & Forecast
1.4.1 Global Antineoplastic Drugs Sales in Value (2016-2026))
1.4.2 Global Antineoplastic Drugs Sales in Volume (2016-2026)
1.4.3 Global Antineoplastic Drugs Price by Type (2016-2026) & (USD/Unit)
1.5 Global Antineoplastic Drugs Production Capacity Analysis
1.5.1 Global Antineoplastic Drugs Total Production Capacity (2016-2026)
1.5.2 Global Antineoplastic Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Antineoplastic Drugs Market Drivers
1.6.2 Antineoplastic Drugs Market Restraints
1.6.3 Antineoplastic Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Hoffmann-La Roche
2.1.1 Hoffmann-La Roche Details
2.1.2 Hoffmann-La Roche Major Business
2.1.3 Hoffmann-La Roche Antineoplastic Drugs Product and Services
2.1.4 Hoffmann-La Roche Antineoplastic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Amgen
2.2.1 Amgen Details
2.2.2 Amgen Major Business
2.2.3 Amgen Antineoplastic Drugs Product and Services
2.2.4 Amgen Antineoplastic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Bristol-Myers Squibb
2.3.1 Bristol-Myers Squibb Details
2.3.2 Bristol-Myers Squibb Major Business
2.3.3 Bristol-Myers Squibb Antineoplastic Drugs Product and Services
2.3.4 Bristol-Myers Squibb Antineoplastic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Baxter Healthcare
2.4.1 Baxter Healthcare Details
2.4.2 Baxter Healthcare Major Business
2.4.3 Baxter Healthcare Antineoplastic Drugs Product and Services
2.4.4 Baxter Healthcare Antineoplastic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Boehringer Ingelheim
2.5.1 Boehringer Ingelheim Details
2.5.2 Boehringer Ingelheim Major Business
2.5.3 Boehringer Ingelheim Antineoplastic Drugs Product and Services
2.5.4 Boehringer Ingelheim Antineoplastic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Aspen Global
2.6.1 Aspen Global Details
2.6.2 Aspen Global Major Business
2.6.3 Aspen Global Antineoplastic Drugs Product and Services
2.6.4 Aspen Global Antineoplastic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Bayer AG
2.7.1 Bayer AG Details
2.7.2 Bayer AG Major Business
2.7.3 Bayer AG Antineoplastic Drugs Product and Services
2.7.4 Bayer AG Antineoplastic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Teva pharmaceutical Industries
2.8.1 Teva pharmaceutical Industries Details
2.8.2 Teva pharmaceutical Industries Major Business
2.8.3 Teva pharmaceutical Industries Antineoplastic Drugs Product and Services
2.8.4 Teva pharmaceutical Industries Antineoplastic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Johnson & Johnson
2.9.1 Johnson & Johnson Details
2.9.2 Johnson & Johnson Major Business
2.9.3 Johnson & Johnson Antineoplastic Drugs Product and Services
2.9.4 Johnson & Johnson Antineoplastic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 Merc & Co.
2.10.1 Merc & Co. Details
2.10.2 Merc & Co. Major Business
2.10.3 Merc & Co. Antineoplastic Drugs Product and Services
2.10.4 Merc & Co. Antineoplastic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.11 Pfize
2.11.1 Pfize Details
2.11.2 Pfize Major Business
2.11.3 Pfize Antineoplastic Drugs Product and Services
2.11.4 Pfize Antineoplastic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.12 Accord Healthcare
2.12.1 Accord Healthcare Details
2.12.2 Accord Healthcare Major Business
2.12.3 Accord Healthcare Antineoplastic Drugs Product and Services
2.12.4 Accord Healthcare Antineoplastic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.13 Genentech
2.13.1 Genentech Details
2.13.2 Genentech Major Business
2.13.3 Genentech Antineoplastic Drugs Product and Services
2.13.4 Genentech Antineoplastic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.14 Lundbeck
2.14.1 Lundbeck Details
2.14.2 Lundbeck Major Business
2.14.3 Lundbeck Antineoplastic Drugs Product and Services
2.14.4 Lundbeck Antineoplastic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.15 AbbVie
2.15.1 AbbVie Details
2.15.2 AbbVie Major Business
2.15.3 AbbVie Antineoplastic Drugs Product and Services
2.15.4 AbbVie Antineoplastic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Antineoplastic Drugs Sales by Manufacturer
3.1 Global Antineoplastic Drugs Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Antineoplastic Drugs Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Antineoplastic Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Antineoplastic Drugs Manufacturer Market Share
3.4.2 Top 6 Antineoplastic Drugs Manufacturer Market Share
3.5 Global Antineoplastic Drugs Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Antineoplastic Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Antineoplastic Drugs Market Size by Region
4.1.1 Global Antineoplastic Drugs Sales in Volume by Region (2016-2026)
4.1.2 Global Antineoplastic Drugs Revenue by Region (2016-2026)
4.2 North America Antineoplastic Drugs Revenue (2016-2026)
4.3 Europe Antineoplastic Drugs Revenue (2016-2026)
4.4 Asia-Pacific Antineoplastic Drugs Revenue (2016-2026)
4.5 South America Antineoplastic Drugs Revenue (2016-2026)
4.6 Middle East and Africa Antineoplastic Drugs Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Antineoplastic Drugs Sales in Volume by Type (2016-2026)
5.2 Global Antineoplastic Drugs Revenue by Type (2016-2026)
5.3 Global Antineoplastic Drugs Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Antineoplastic Drugs Sales in Volume by Application (2016-2026)
6.2 Global Antineoplastic Drugs Revenue by Application (2016-2026)
6.3 Global Antineoplastic Drugs Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Antineoplastic Drugs Sales by Type (2016-2026)
7.2 North America Antineoplastic Drugs Sales by Application (2016-2026)
7.3 North America Antineoplastic Drugs Market Size by Country
7.3.1 North America Antineoplastic Drugs Sales in Volume by Country (2016-2026)
7.3.2 North America Antineoplastic Drugs Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Antineoplastic Drugs Sales by Type (2016-2026)
8.2 Europe Antineoplastic Drugs Sales by Application (2016-2026)
8.3 Europe Antineoplastic Drugs Market Size by Country
8.3.1 Europe Antineoplastic Drugs Sales in Volume by Country (2016-2026)
8.3.2 Europe Antineoplastic Drugs Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Antineoplastic Drugs Sales by Type (2016-2026)
9.2 Asia-Pacific Antineoplastic Drugs Sales by Application (2016-2026)
9.3 Asia-Pacific Antineoplastic Drugs Market Size by Region
9.3.1 Asia-Pacific Antineoplastic Drugs Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Antineoplastic Drugs Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Antineoplastic Drugs Sales by Type (2016-2026)
10.2 South America Antineoplastic Drugs Sales by Application (2016-2026)
10.3 South America Antineoplastic Drugs Market Size by Country
10.3.1 South America Antineoplastic Drugs Sales in Volume by Country (2016-2026)
10.3.2 South America Antineoplastic Drugs Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Antineoplastic Drugs Sales by Type (2016-2026)
11.2 Middle East & Africa Antineoplastic Drugs Sales by Application (2016-2026)
11.3 Middle East & Africa Antineoplastic Drugs Market Size by Country
11.3.1 Middle East & Africa Antineoplastic Drugs Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Antineoplastic Drugs Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Antineoplastic Drugs Typical Distributors
12.3 Antineoplastic Drugs Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Antineoplastic Drugs Revenue by Type, (USD Million), 2021-2026
Table 2. Global Antineoplastic Drugs Revenue by Application, (USD Million), 2021-2026
Table 3. Hoffmann-La Roche Basic Information, Manufacturing Base and Competitors
Table 4. Hoffmann-La Roche Major Business
Table 5. Hoffmann-La Roche Antineoplastic Drugs Product and Services
Table 6. Hoffmann-La Roche Antineoplastic Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Amgen Basic Information, Manufacturing Base and Competitors
Table 8. Amgen Major Business
Table 9. Amgen Antineoplastic Drugs Product and Services
Table 10. Amgen Antineoplastic Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 12. Bristol-Myers Squibb Major Business
Table 13. Bristol-Myers Squibb Antineoplastic Drugs Product and Services
Table 14. Bristol-Myers Squibb Antineoplastic Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Baxter Healthcare Basic Information, Manufacturing Base and Competitors
Table 16. Baxter Healthcare Major Business
Table 17. Baxter Healthcare Antineoplastic Drugs Product and Services
Table 18. Baxter Healthcare Antineoplastic Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 20. Boehringer Ingelheim Major Business
Table 21. Boehringer Ingelheim Antineoplastic Drugs Product and Services
Table 22. Boehringer Ingelheim Antineoplastic Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Aspen Global Basic Information, Manufacturing Base and Competitors
Table 24. Aspen Global Major Business
Table 25. Aspen Global Antineoplastic Drugs Product and Services
Table 26. Aspen Global Antineoplastic Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Bayer AG Basic Information, Manufacturing Base and Competitors
Table 28. Bayer AG Major Business
Table 29. Bayer AG Antineoplastic Drugs Product and Services
Table 30. Bayer AG Antineoplastic Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Teva pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 32. Teva pharmaceutical Industries Major Business
Table 33. Teva pharmaceutical Industries Antineoplastic Drugs Product and Services
Table 34. Teva pharmaceutical Industries Antineoplastic Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 36. Johnson & Johnson Major Business
Table 37. Johnson & Johnson Antineoplastic Drugs Product and Services
Table 38. Johnson & Johnson Antineoplastic Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Merc & Co. Basic Information, Manufacturing Base and Competitors
Table 40. Merc & Co. Major Business
Table 41. Merc & Co. Antineoplastic Drugs Product and Services
Table 42. Merc & Co. Antineoplastic Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Pfize Basic Information, Manufacturing Base and Competitors
Table 44. Pfize Major Business
Table 45. Pfize Antineoplastic Drugs Product and Services
Table 46. Pfize Antineoplastic Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Accord Healthcare Basic Information, Manufacturing Base and Competitors
Table 48. Accord Healthcare Major Business
Table 49. Accord Healthcare Antineoplastic Drugs Product and Services
Table 50. Accord Healthcare Antineoplastic Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Genentech Basic Information, Manufacturing Base and Competitors
Table 52. Genentech Major Business
Table 53. Genentech Antineoplastic Drugs Product and Services
Table 54. Genentech Antineoplastic Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Lundbeck Basic Information, Manufacturing Base and Competitors
Table 56. Lundbeck Major Business
Table 57. Lundbeck Antineoplastic Drugs Product and Services
Table 58. Lundbeck Antineoplastic Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. AbbVie Basic Information, Manufacturing Base and Competitors
Table 60. AbbVie Major Business
Table 61. AbbVie Antineoplastic Drugs Product and Services
Table 62. AbbVie Antineoplastic Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 63. Global Antineoplastic Drugs Sales by Manufacturer (2019-2021e) & (K Units)
Table 64. Global Antineoplastic Drugs Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 65. Market Position of Manufacturers in Antineoplastic Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 66. Global Antineoplastic Drugs Production Capacity by Company, (K Units): 2020 VS 2021
Table 67. Head Office and Antineoplastic Drugs Production Site of Key Manufacturer
Table 68. Global Antineoplastic Drugs Sales by Region (2016-2021e) & (K Units)
Table 69. Global Antineoplastic Drugs Sales by Region (2021-2026) & (K Units)
Table 70. Global Antineoplastic Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 71. Global Antineoplastic Drugs Revenue by Region (2021-2026) & (USD Million)
Table 72. Global Antineoplastic Drugs Sales by Type (2016-2021e) & (K Units)
Table 73. Global Antineoplastic Drugs Sales by Type (2021-2026) & (K Units)
Table 74. Global Antineoplastic Drugs Revenue by Type (2016-2021e) & (USD Million)
Table 75. Global Antineoplastic Drugs Revenue by Type (2021-2026) & (USD Million)
Table 76. Global Antineoplastic Drugs Price by Type (2016-2021e) & (USD/Unit)
Table 77. Global Antineoplastic Drugs Price by Type (2021-2026) & (USD/Unit)
Table 78. Global Antineoplastic Drugs Sales by Application (2016-2021e) & (K Units)
Table 79. Global Antineoplastic Drugs Sales by Application (2021-2026) & (K Units)
Table 80. Global Antineoplastic Drugs Revenue by Application (2016-2021e) & (USD Million)
Table 81. Global Antineoplastic Drugs Revenue by Application (2021-2026) & (USD Million)
Table 82. Global Antineoplastic Drugs Price by Application (2016-2021e) & (USD/Unit)
Table 83. Global Antineoplastic Drugs Price by Application (2021-2026) & (USD/Unit)
Table 84. North America Antineoplastic Drugs Sales by Country (2016-2021e) & (K Units)
Table 85. North America Antineoplastic Drugs Sales by Country (2021-2026) & (K Units)
Table 86. North America Antineoplastic Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 87. North America Antineoplastic Drugs Revenue by Country (2021-2026) & (USD Million)
Table 88. North America Antineoplastic Drugs Sales by Type (2016-2021e) & (K Units)
Table 89. North America Antineoplastic Drugs Sales by Type (2021-2026) & (K Units)
Table 90. North America Antineoplastic Drugs Sales by Application (2016-2021e) & (K Units)
Table 91. North America Antineoplastic Drugs Sales by Application (2021-2026) & (K Units)
Table 92. Europe Antineoplastic Drugs Sales by Country (2016-2021e) & (K Units)
Table 93. Europe Antineoplastic Drugs Sales by Country (2021-2026) & (K Units)
Table 94. Europe Antineoplastic Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 95. Europe Antineoplastic Drugs Revenue by Country (2021-2026) & (USD Million)
Table 96. Europe Antineoplastic Drugs Sales by Type (2016-2021e) & (K Units)
Table 97. Europe Antineoplastic Drugs Sales by Type (2021-2026) & (K Units)
Table 98. Europe Antineoplastic Drugs Sales by Application (2016-2021e) & (K Units)
Table 99. Europe Antineoplastic Drugs Sales by Application (2021-2026) & (K Units)
Table 100. Asia-Pacific Antineoplastic Drugs Sales by Region (2016-2021e) & (K Units)
Table 101. Asia-Pacific Antineoplastic Drugs Sales by Region (2021-2026) & (K Units)
Table 102. Asia-Pacific Antineoplastic Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 103. Asia-Pacific Antineoplastic Drugs Revenue by Region (2021-2026) & (USD Million)
Table 104. Asia-Pacific Antineoplastic Drugs Sales by Type (2016-2021e) & (K Units)
Table 105. Asia-Pacific Antineoplastic Drugs Sales by Type (2021-2026) & (K Units)
Table 106. Asia-Pacific Antineoplastic Drugs Sales by Application (2016-2021e) & (K Units)
Table 107. Asia-Pacific Antineoplastic Drugs Sales by Application (2021-2026) & (K Units)
Table 108. South America Antineoplastic Drugs Sales by Country (2016-2021e) & (K Units)
Table 109. South America Antineoplastic Drugs Sales by Country (2021-2026) & (K Units)
Table 110. South America Antineoplastic Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 111. South America Antineoplastic Drugs Revenue by Country (2021-2026) & (USD Million)
Table 112. South America Antineoplastic Drugs Sales by Type (2016-2021e) & (K Units)
Table 113. South America Antineoplastic Drugs Sales by Type (2021-2026) & (K Units)
Table 114. South America Antineoplastic Drugs Sales by Application (2016-2021e) & (K Units)
Table 115. South America Antineoplastic Drugs Sales by Application (2021-2026) & (K Units)
Table 116. Middle East & Africa Antineoplastic Drugs Sales by Country (2016-2021e) & (K Units)
Table 117. Middle East & Africa Antineoplastic Drugs Sales by Country (2021-2026) & (K Units)
Table 118. Middle East & Africa Antineoplastic Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 119. Middle East & Africa Antineoplastic Drugs Revenue by Country (2021-2026) & (USD Million)
Table 120. Middle East & Africa Antineoplastic Drugs Sales by Type (2016-2021e) & (K Units)
Table 121. Middle East & Africa Antineoplastic Drugs Sales by Type (2021-2026) & (K Units)
Table 122. Middle East & Africa Antineoplastic Drugs Sales by Application (2016-2021e) & (K Units)
Table 123. Middle East & Africa Antineoplastic Drugs Sales by Application (2021-2026) & (K Units)
Table 124. Direct Channel Pros & Cons
Table 125. Indirect Channel Pros & Cons
Table 126. Antineoplastic Drugs Typical Distributors
Table 127. Antineoplastic Drugs Typical Customers
List of Figures
Figure 1. Antineoplastic Drugs Picture
Figure 2. Global Antineoplastic Drugs Sales Market Share by Type in 2020
Figure 3. Chemotherapeutic Agents
Figure 4. Biological/Immunotherapeutic Agents
Figure 5. Personalized Medicine
Figure 6. Global Antineoplastic Drugs Sales Market Share by Application in 2020
Figure 7. Hospitals
Figure 8. Clinics
Figure 9. Cancer Rehabilitation Centers
Figure 10. Ambulatory Surgical Centers
Figure 11. Global Antineoplastic Drugs Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 12. Global Antineoplastic Drugs Market Size and Forecast (2016-2026) & (USD Million)
Figure 13. United States Antineoplastic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Canada Antineoplastic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Mexico Antineoplastic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. Germany Antineoplastic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. France Antineoplastic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. United Kingdom Antineoplastic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Russia Antineoplastic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Italy Antineoplastic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. China Antineoplastic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Japan Antineoplastic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Korea Antineoplastic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. India Antineoplastic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Southeast Asia Antineoplastic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Australia Antineoplastic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Brazil Antineoplastic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Egypt Antineoplastic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Saudi Arabia Antineoplastic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. South Africa Antineoplastic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Turkey Antineoplastic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 32. Global Antineoplastic Drugs Sales (2016-2026) & (K Units)
Figure 33. Global Antineoplastic Drugs Production Capacity (2016-2026) & (K Units)
Figure 34. Global Antineoplastic Drugs Production Capacity by Geographic Region: 2020 VS 2021
Figure 35. Antineoplastic Drugs Market Drivers
Figure 36. Antineoplastic Drugs Market Restraints
Figure 37. Antineoplastic Drugs Market Trends
Figure 38. Global Antineoplastic Drugs Sales Market Share by Manufacturer in 2020
Figure 39. Global Antineoplastic Drugs Revenue Market Share by Manufacturer in 2020
Figure 40. Antineoplastic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 41. Top 3 Antineoplastic Drugs Manufacturer (Revenue) Market Share in 2020
Figure 42. Top 6 Antineoplastic Drugs Manufacturer (Revenue) Market Share in 2020
Figure 43. Global Antineoplastic Drugs Sales Market Share by Region (2016-2026)
Figure 44. Global Antineoplastic Drugs Revenue Market Share by Region (2016-2026)
Figure 45. North America Antineoplastic Drugs Revenue (2016-2026) & (USD Million)
Figure 46. Europe Antineoplastic Drugs Revenue (2016-2026) & (USD Million)
Figure 47. Asia-Pacific Antineoplastic Drugs Revenue (2016-2026) & (USD Million)
Figure 48. South America Antineoplastic Drugs Revenue (2016-2026) & (USD Million)
Figure 49. Middle East & Africa Antineoplastic Drugs Revenue (2016-2026) & (USD Million)
Figure 50. Global Antineoplastic Drugs Sales Market Share by Type (2016-2026)
Figure 51. Global Antineoplastic Drugs Revenue Market Share by Type (2016-2026)
Figure 52. Global Antineoplastic Drugs Price by Type (2016-2026) & (USD/Unit)
Figure 53. Global Antineoplastic Drugs Sales Market Share by Application (2016-2026)
Figure 54. Global Antineoplastic Drugs Revenue Market Share by Application (2016-2026)
Figure 55. Global Antineoplastic Drugs Price by Application (2016-2026) & (USD/Unit)
Figure 56. North America Antineoplastic Drugs Sales Market Share by Country (2016-2026)
Figure 57. North America Antineoplastic Drugs Revenue Market Share by Country (2016-2026)
Figure 58. North America Antineoplastic Drugs Sales Market Share by Type (2016-2026)
Figure 59. North America Antineoplastic Drugs Sales Market Share by Application (2016-2026)
Figure 60. Europe Antineoplastic Drugs Sales Market Share by Country (2016-2026)
Figure 61. Europe Antineoplastic Drugs Revenue Market Share by Country (2016-2026)
Figure 62. Europe Antineoplastic Drugs Sales Market Share by Type (2016-2026)
Figure 63. Europe Antineoplastic Drugs Sales Market Share by Application (2016-2026)
Figure 64. Asia-Pacific Antineoplastic Drugs Sales Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Antineoplastic Drugs Revenue Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Antineoplastic Drugs Sales Market Share by Region (2016-2026)
Figure 67. Asia-Pacific Antineoplastic Drugs Sales Market Share by Application (2016-2026)
Figure 68. South America Antineoplastic Drugs Sales Market Share by Country (2016-2026)
Figure 69. South America Antineoplastic Drugs Revenue Market Share by Country (2016-2026)
Figure 70. South America Antineoplastic Drugs Sales Market Share by Type (2016-2026)
Figure 71. South America Antineoplastic Drugs Sales Market Share by Application (2016-2026)
Figure 72. Middle East & Africa Antineoplastic Drugs Sales Market Share by Country (2016-2026)
Figure 73. Middle East & Africa Antineoplastic Drugs Revenue Market Share by Country (2016-2026)
Figure 74. Middle East & Africa Antineoplastic Drugs Sales Market Share by Type (2016-2026)
Figure 75. Middle East & Africa Antineoplastic Drugs Sales Market Share by Application (2016-2026)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
Figure 77. Methodology
Figure 78. Research Process and Data Source
世界の尿路上皮がん治療薬市場 2021：企業別、地域別、種類・用途別 The Urothelial Cancer Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulat…- 世界の膵臓がん治療薬市場 2021：企業別、地域別、種類・用途別 The Pancreatic Cancer Treatment Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tra…
- 世界のメトトレキサート薬市場 2021：企業別、地域別、種類・用途別 The Methotrexate Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations,…
- 世界のクロファラビン薬市場 2021：企業別、地域別、種類・用途別 The Clofarabine Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, …
- 世界のメシル酸イマチニブ薬市場 2021：企業別、地域別、種類・用途別 The Imatinib Mesylate Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulat…